Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.
Garaventa A, Poetschger U, Valteau-Couanet D, Luksch R, Castel V, Elliott M, Ash S, Chan GCF, Laureys G, Beck-Popovic M, Vettenranta K, Balwierz W, Schroeder H, Owens C, Cesen M, Papadakis V, Trahair T, Schleiermacher G, Ambros P, Sorrentino S, Pearson ADJ, Ladenstein RL. Garaventa A, et al. Among authors: luksch r. J Clin Oncol. 2021 Aug 10;39(23):2552-2563. doi: 10.1200/JCO.20.03144. Epub 2021 Jun 21. J Clin Oncol. 2021. PMID: 34152804 Clinical Trial.
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Spreafico F, Massimino M, Luksch R, Casanova M, Cefalo GS, Collini P, Ferrari A, Polastri D, Terenziani M, Gasparini M, Fossati-Bellani F. Spreafico F, et al. Among authors: luksch r. J Clin Oncol. 2002 Jun 15;20(12):2783-8. doi: 10.1200/JCO.2002.08.088. J Clin Oncol. 2002. PMID: 12065554 Clinical Trial.
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F. Massimino M, et al. Among authors: luksch r. J Clin Oncol. 2002 Oct 15;20(20):4209-16. doi: 10.1200/JCO.2002.08.087. J Clin Oncol. 2002. PMID: 12377964 Clinical Trial.
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.
Formelli F, Cavadini E, Luksch R, Garaventa A, Villani MG, Appierto V, Persiani S. Formelli F, et al. Among authors: luksch r. Cancer Chemother Pharmacol. 2008 Sep;62(4):655-65. doi: 10.1007/s00280-007-0649-7. Epub 2007 Dec 8. Cancer Chemother Pharmacol. 2008. PMID: 18066548 Clinical Trial.
Retrospective study of childhood ganglioneuroma.
De Bernardi B, Gambini C, Haupt R, Granata C, Rizzo A, Conte M, Tonini GP, Bianchi M, Giuliano M, Luksch R, Prete A, Viscardi E, Garaventa A, Sementa AR, Bruzzi P, Angelini P. De Bernardi B, et al. Among authors: luksch r. J Clin Oncol. 2008 Apr 1;26(10):1710-6. doi: 10.1200/JCO.2006.08.8799. J Clin Oncol. 2008. PMID: 18375900
Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size.
Ferrari A, Miceli R, Meazza C, Zaffignani E, Gronchi A, Piva L, Collini P, Podda M, Massimino M, Luksch R, Cefalo G, Terenziani M, Spreafico F, Polastri D, Fossati-Bellani F, Casanova M, Mariani L. Ferrari A, et al. Among authors: luksch r. J Clin Oncol. 2009 Jan 20;27(3):371-6. doi: 10.1200/JCO.2007.15.4542. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064986
197 results